SEC Form 4 · accession 0001127602-16-063177
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Caroline Dorsa
Director
Period of report
Sep 22, 2016
Accepted (ET)
Sep 26, 2016 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 22, 2016 | M | 2,570 | $53.64 | A | 19,663 | D | |
| Common Stock | Sep 22, 2016 | M | 25,000 | $53.64 | A | 44,663 | D | |
| Common Stock | Sep 22, 2016 | S | 27,570 | $314.00 | D | 17,093 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $53.64 | Sep 22, 2016 | M | 2,570 | D | Jan 4, 2011 | Jan 3, 2020 | Common Stock | 2,570 | 0 | D |
| Stock Option (Right to Buy)F2 | $53.64 | Sep 22, 2016 | M | 25,000 | D | — | Jan 3, 2020 | Common Stock | 25,000 | 0 | D |
Explanation of responses
- F1Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934
- F2The stock options become exercisable in three (3) equal annual installments commencing one year after the grant date of 01/04/2010.